Latest news
Innovation Passports for Liver Cancer and Dementia Treatm... - politicsuk.compoliticsuk.com · Wed, 05 Aug 2026 08:04:23 GMTCervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB) - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 09:15:00 GMTThe Innovative Licensing and Access Pathway grants Innovation Passports to investigational products for cancer and dementia - GOV.UKGOV.UK · Tue, 04 Aug 2026 08:56:29 GMTRecord Chinese biotech out-licensing meets rising US scrutiny - South China Morning PostSouth China Morning Post · Tue, 28 Jul 2026 07:00:00 GMT